Supplemented ERA-EDTA Registry data evaluated the frequency of dialysis, kidney transplantation, and comprehensive conservative management for patients with kidney failure in Europe

V.S. Stel*, R.W. de Jong, A. Kramer, A.M. Andrusev, J.M. Baltar, M. Barbullushi, S. Bell, P.C. de la Nuez, H. Cernevskis, C. Couchoud, J. De Meester, B.O. Eriksen, L. Garneata, E. Golan, J. Helve, M.H. Hemmelder, K. Hommel, K. Ioannou, F. Jarraya, N. KantariaJ. Kerschbaum, K.S. Komissarov, A. Magaz, L. Mercadal, M. Ots-Rosenberg, R. Palsson, A. Rahmel, H. Rydell, M. Savino, N. Seyahi, M.F.S. Roblero, O. Stojceva-Taneva, A. van der Tol, E.S. Vazelov, E. Ziginskiene, O. Zurriaga, R.C. Vanholder, Z.A. Massy, K.J. Jager

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

12 Citations (Web of Science)


The aims of this study were to determine the frequency of dialysis and kidney transplantation and to estimate the regularity of comprehensive conservative management (CCM) for patients with kidney failure in Europe. This study uses data from the ERA-EDTA Registry. Additionally, our study included supplemental data from Armenia, Germany, Hungary, Ireland, Kosovo, Luxembourg, Malta, Moldova, Montenegro, Slovenia and additional data from Israel, Italy, Slovakia using other information sources. Through an online survey, responding nephrologists estimated the frequency of CCM (i.e. planned holistic care instead of kidney replacement therapy) in 33 countries. In 2016, the overall incidence of replacement therapy for kidney failure was 132 per million population (pmp), varying from 29 (Ukraine) to 251 pmp (Greece). On 31 December 2016, the overall prevalence of kidney replacement therapy was 985 pmp, ranging from 188 (Ukraine) to 1906 pmp (Portugal). The prevalence of peritoneal dialysis (114 pmp) and home hemodialysis (28 pmp) was highest in Cyprus and Denmark respectively. The kidney transplantation rate was nearly zero in some countries and highest in Spain (64 pmp). In 28 countries with five or more responding nephrologists, the median percentage of candidates for kidney replacement therapy who were offered CCM in 2018 varied between none (Slovakia and Slovenia) and 20% (Finland) whereas the median prevalence of CCM varied between none (Slovenia) and 15% (Hungary). Thus, the substantial differences across Europe in the frequency of kidney replacement therapy and CCM indicate the need for improvement in access to various treatment options for patients with kidney failure.
Original languageEnglish
Pages (from-to)182-195
Number of pages14
JournalKidney International
Issue number1
Publication statusPublished - 1 Jul 2021


  • hemodialysis
  • peritoneal dialysis
  • transplantation
  • CARE

Cite this